Skip to main content

Weather Alert

Due to hurricane Idalia, our Patient Service Centers in affected areas may be closed. For site-specific information, please use Find a location and enter your zip code.

Hide

Get the right leukemia insights with our broad testing portfolio

Whether you need peripheral blood panels, a comprehensive diagnosis on a bone marrow biopsy, or a “hard to find” molecular assay, we power innovative solutions to address the specific needs of your practice or laboratory with our comprehensive menu of routine and specialized hematopathology testing services.

Acute Myeloid Leukemia (AML)

Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that progresses very quickly. Therefore, prompt diagnosis improves outcomes.

Acute lymphocytic leukemia (ALL)

Quest Diagnostics employs the FISH panel to identify the TEL/AML1 gene fusion that is usually undetectable by conventional chromosome analysis used to screen for acute lymphoblastic leukemia (ALL).

Chronic lymphocytic leukemia (CLL)

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. In some cases, the disease can be aggressive and within a year the tumor mass may increase significantly imposing serious health problems to the patient.

Chronic myeloid leukemia (CML)

Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow.1

Leukemia tests

This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

 

References

 

  1. American Cancer Society. What Is chronic myeloid leukemia? Updated June 19, 2018. Accessed August 4, 2021. https://www.cancer.org/cancer/chronic-myeloid-leukemia/about/what-is-cml.html

During the COVID-19 health crisis, fast action and trusted information matter more than ever.

Find out what's happening

Learn More